Form 4: Quest Diagnostics Director Acquires Restricted Share Units

Luis Diaz, a director at Quest Diagnostics, acquired 1,482 restricted share units on May 16, 2024.

Summary

• On May 16, 2024, Luis Diaz, a director of Quest Diagnostics, acquired 1,482 shares of common stock in the form of restricted share units.
• The acquisition was direct and the price was $0.
• Following the transaction, Diaz directly owns 2,851 shares of Quest Diagnostics common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard disclosure of a transaction. The acquisition of shares by a director is generally viewed as a positive, but it's a relatively small amount.

Positives

• The acquisition of restricted share units by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company directors and officers, which can be informative for investors.

Stakeholder Impact

• The acquisition of shares by a director may have a slightly positive impact on shareholder sentiment.

Key Dates